Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 032300306 approvals47 trials

KOREA PHARMA Co., Ltd.

Official website

KOSDAQ-listed pharmaceutical company exporting to 17 countries, combining finished-drug manufacturing with CMO contract manufacturing.

As of 2026-10-09, KOREA PHARMA Co., Ltd. has 306 Korean MFDS drug approvals, 5 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1985 and listed on the KOSDAQ in 2020, Korea Pharma is a pharmaceutical company specializing in CNS, gastrointestinal, cardiovascular, and antibacterial drugs. It manufactures and sells finished pharmaceuticals while also running a CMO business for solid dosage forms, oral liquids, topical liquids, and ointments, and has obtained EU GMP certification for its topical liquid/lotion products. As of 2025 it exported roughly KRW 2.2 billion worth of goods, registering and exporting around 60 self-manufactured products to 17 countries including Yemen, Myanmar, Vietnam, Nigeria, and Azerbaijan, and it also runs a domestic/overseas out-licensing business, having assigned a patent for an oral pharmaceutical composition containing choline alfoscerate to Daewoong Bio Co. in 2017.

Regulatory approvals

data.go.kr

306 Korean MFDS drug approvals · 1985–2026

  • MFDS drugQuety tab. 12.5mg2026-04-22
    Drug · Prescription · Approval202601183
  • MFDS drugPharma tegoprazan 25mg2026-04-14
    Drug · Prescription · Approval202601071
  • MFDS drugPharma tegoprazan 50mg2026-04-14
    Drug · Prescription · Approval202601072
  • MFDS drugQuety tab. 50mg2026-03-17
    Drug · Prescription · Approval202600767
  • MFDS drugAccrufer Cap.2025-11-05
    Drug · Prescription · Approval202502868
  • MFDS drugOlzapex Tab. 2.5mg2025-07-30
    Drug · Prescription · Approval202501982
  • MFDS drugPharma Naratriptan ODT 2.5mg(Naratriptan Hydrochloride)2024-12-09
    Drug · Prescription · Approval202402899
  • MFDS drugPharma Mirtazapine Tab. 15mg2024-11-25
    Drug · Prescription · Approval202402770
  • MFDS drugPharma Mirtazapine Tab. 7.5mg2024-11-25
    Drug · Prescription · Approval202402771
  • MFDS drugPharma Mirtazapine Tab. 30mg2024-11-25
    Drug · Prescription · Approval202402772
  • MFDS drugAratect Cap.100/5mg2024-09-27
    Drug · Prescription · Approval202402338
  • MFDS drugpharma efinaconazole topical solution2024-08-13
    Drug · Prescription · Approval202401944
Show 68 more
  • MFDS drugPharma Nicergoline tab. 30mg2024-06-28
    Drug · Prescription · Approval202401572
  • MFDS drugPharma Desvenlafaxine ER Tab. 50mg2024-06-27
    Drug · Prescription · Approval202401555
  • MFDS drugAlbix Tab. 20mg2024-06-26
    Drug · Prescription · Approval202401543
  • MFDS drugAlbix Tab. 5mg2024-06-12
    Drug · Prescription · Approval202401435
  • MFDS drugPharma Melatonin PR Tab. 2mg2024-05-30
    Drug · Prescription · Approval202401343
  • MFDS drugPharma Desvenlafaxine ER Tab. 100mg2024-03-21
    Drug · Prescription · Approval202400587
  • MFDS drugDivalpro ER Tab. 250mg2023-12-27
    Drug · Prescription · Approval202303449
  • MFDS drugGinmacton Tab. 240mg2023-12-07
    Drug · OTC · Notification202303309
  • MFDS drugDivalpro ER Tab. 500mg2023-11-08
    Drug · Prescription · Approval202303094
  • MFDS drugPharma Empalow duo Tab. 12.5/1000mg2023-09-05
    Drug · Prescription · Approval202302642
  • MFDS drugPharma Empalow duo Tab. 12.5/850mg2023-09-05
    Drug · Prescription · Approval202302643
  • MFDS drugPharma Empalow duo Tab. 12.5/500mg2023-09-05
    Drug · Prescription · Approval202302644
  • MFDS drugPharma doxepin Tab. 3mg2023-06-14
    Drug · Prescription · Notification202301840
  • MFDS drugPharma doxepin Tab. 6mg2023-06-14
    Drug · Prescription · Notification202301841
  • MFDS drugPharma Mini Mega soft Cap. 500mg2023-03-30
    Drug · Prescription · Approval202301078
  • MFDS drugArabil tab. 1mg2023-03-09
    Drug · Prescription · Approval202300817
  • MFDS drugCrirol Solution2023-01-04
    Drug · OTC · Approval202300044
  • MFDS drugSalopram Tab. 15mg2022-11-28
    Drug · Prescription · Approval202204261
  • MFDS drugPharma Trimebutine tab. 100mg(for export)(AMATASE Tab. 100mg)2022-10-27
    Drug · OTC · Notification202203922
  • MFDS drugZero moo once Topical Solution (Terbinafine Hydrochloride)2022-10-13
    Drug · OTC · Notification202203820
  • MFDS drugArabil tab. 2mg2022-09-08
    Drug · Prescription · Approval202203530
  • MFDS drugRabetan tab. 20/800mg2022-06-30
    Drug · Prescription · Approval202202686
  • MFDS drugAzelia tab. 16mg2022-06-13
    Drug · Prescription · Approval202202475
  • MFDS drugPharma Empalow duo Tab. 5/850mg2022-04-26
    Drug · Prescription · Approval202201695
  • MFDS drugPharma Empalow duo Tab. 5/500mg2022-04-26
    Drug · Prescription · Approval202201696
  • MFDS drugPharma Empalow duo Tab. 5/1000mg2022-04-26
    Drug · Prescription · Approval202201697
  • MFDS drugAzelia tab. 8mg2021-12-28
    Drug · Prescription · Approval202108119
  • MFDS drugPharma Buspirone Tab. 10mg2021-09-15
    Drug · Prescription · Approval202106544
  • MFDS drugPharma Buspirone Tab. 5mg2021-09-15
    Drug · Prescription · Approval202106545
  • MFDS drugZero moo nail lacquer2021-07-29
    Drug · OTC · Notification202105619
  • MFDS drugEsotan Tab. 20/800mg2021-06-18
    Drug · Prescription · Approval202104750
  • MFDS drugVastia Tab 23mgRevoked2021-04-29
    Drug · Prescription · Approval202103492
  • MFDS drugPharma eszopiclone Tab. 3mgRevoked2021-04-26
    Drug · Prescription · Approval202103385
  • MFDS drugPharma eszopiclone Tab. 1mgRevoked2021-04-26
    Drug · Prescription · Approval202103386
  • MFDS drugPharma eszopiclone Tab. 2mgRevoked2021-04-26
    Drug · Prescription · Approval202103387
  • MFDS drugPharma Empalow Tab. 25mg2021-03-31
    Drug · Prescription · Approval202102824
  • MFDS drugPharma Empalow Tab. 10mg2021-03-31
    Drug · Prescription · Approval202102825
  • MFDS drugPharmaSodiumSeleniteRevoked2020-11-20
    Drug · Prescription · Notification202008067
  • MFDS drugPharma Dapagliflozin Tab. 10mgRevoked2020-06-17
    Drug · Prescription · Approval202004455
  • MFDS drugPharma Polaprezinc Tab2020-05-21
    Drug · Prescription · Approval202003716
  • MFDS drugPharma Omega Soft Cap.2020-04-29
    Drug · Prescription · Approval202003229
  • MFDS drugPharma Mosapride SR Tab. 15mg2020-04-28
    Drug · Prescription · Approval202003166
  • MFDS drugPharma Lafutidine Tab.2020-04-24
    Drug · Prescription · Approval202002962
  • MFDS drugPharma Sertraline Tab. 100mg2020-02-20
    Drug · Prescription · Approval202001212
  • MFDS drugPharma Sertraline Tab. 25mg2020-02-20
    Drug · Prescription · Approval202001213
  • MFDS drugPharma Rasagiline Tab. 0.5mgRevoked2020-01-31
    Drug · Prescription · Approval202000508
  • MFDS drugTripgel Suspension (for export)2020-01-29
    Drug · OTC · Notification202000466
  • MFDS drugPharma Tiropramide HCl Tab. 100mg2019-12-23
    Drug · Prescription · Approval201908586
  • MFDS drugElpion Tab. 25mg2019-12-23
    Drug · Prescription · Approval201908596
  • MFDS drugPharma Sertraline Tab. 50mg2019-12-03
    Drug · Prescription · Approval201908216
  • MFDS drugPharma Tadalafil ODF. 5mgRevoked2019-11-12
    Drug · Prescription · Approval201907876
  • MFDS drugPharma Tadalafil ODF. 20mgRevoked2019-11-12
    Drug · Prescription · Approval201907877
  • MFDS drugPharma Tadalafil ODF. 10mgRevoked2019-11-12
    Drug · Prescription · Approval201907878
  • MFDS drugPharma Rasagiline Tab.Revoked2019-10-22
    Drug · Prescription · Approval201907383
  • MFDS drugNizatid Tab. 150mg2019-10-18
    Drug · Prescription · Approval201907346
  • MFDS drugPlenvu Powder2019-08-09
    Drug · Prescription · Approval201905631
  • MFDS drugPharma Theobromine Cap.Revoked2019-07-17
    Drug · Prescription · Notification201904793
  • MFDS drugPharma Epinastine HCl Tab. 20mgRevoked2019-07-11
    Drug · Prescription · Approval201904682
  • MFDS drugPharma Epinastine HCl Tab. 10mgRevoked2019-07-11
    Drug · Prescription · Approval201904683
  • MFDS drugPhama Aceclofenac CR Tab.2019-06-20
    Drug · Prescription · Approval201904284
  • MFDS drugPharma Irsogladine Maleate Tab. 2mgRevoked2019-05-31
    Drug · Prescription · Approval201903613
  • MFDS drugPharma Irsogladine Maleate Tab. 4mgRevoked2019-05-31
    Drug · Prescription · Approval201903614
  • MFDS drugMasafo SR Tab. 300mg2019-05-28
    Drug · Prescription · Approval201903474
  • MFDS drugSalopram Tab. 5mg2019-05-21
    Drug · Prescription · Approval201903284
  • MFDS drugPharma Roxithromycin Tab.Revoked2019-05-15
    Drug · Prescription · Approval201903154
  • MFDS drugCholitirin Syrup2019-03-29
    Drug · Prescription · Approval201901953
  • MFDS drugRopirino SR Tab. 2mgRevoked2019-03-07
    Drug · Prescription · Approval201901415
  • MFDS drugRopirino SR Tab. 8mgRevoked2019-03-07
    Drug · Prescription · Approval201901423

Showing the 80 most recent of 306 records.

Clinical trials

data.go.kr

47 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 41 · Phase 1 5 · Phase 2 1)

  • Phase 1KP-25022026-03-23

    2 trial sites

  • Phase 1KP25012025-11-06

    2 trial sites

  • Phase 1KP24032025-03-31

    2 trial sites

  • Bioequivalence쿠에티정12.5밀리그램(쿠에티아핀푸마르산염)2024-06-04

    2 trial sites

  • BioequivalenceKP22032023-06-28

    2 trial sites

  • BioequivalenceKP22032023-06-23

    2 trial sites

  • BioequivalenceKP23012023-06-21

    2 trial sites

  • Bioequivalence아드펜정(펜디메트라진타르타르산염)2023-04-21

    2 trial sites

  • Bioequivalence파마프로시클리딘정2023-04-17

    2 trial sites

  • BioequivalenceKP21042022-09-29

    2 trial sites

  • Phase 1아크루퍼 (KP-01)2022-08-23

    1 trial site

  • Bioequivalence파마벤라팍신서방캡슐75밀리그램(벤라팍신염산염)2021-09-29

    2 trial sites

Show 35 more
  • Bioequivalence파피온서방정(부프로피온염산염)2021-06-29

    2 trial sites

  • Bioequivalence파피온서방정(부프로피온염산염)2021-06-25

    2 trial sites

  • Bioequivalence파마데스벤라팍신서방정100밀리그램(데스벤라팍신숙신산염일수화물)2021-03-16

    2 trial sites

  • Bioequivalence파마데스벤라팍신서방정100밀리그램(데스벤라팍신숙신산염일수화물)2021-03-15

    2 trial sites

  • Bioequivalence파마벤라팍신서방캡슐75밀리그램(벤라팍신염산염)2021-03-09

    2 trial sites

  • Bioequivalence임상시험계획승인신청중2021-03-02

    2 trial sites

  • Bioequivalence파마디발프로엑스서방정500밀리그램(디발프로엑스나트륨)2021-02-26

    2 trial sites

  • Bioequivalence파마벤라팍신서방캡슐75밀리그램(벤라팍신염산염)2021-02-23

    2 trial sites

  • Bioequivalence파마파록세틴씨알정25밀리그램(파록세틴염산염수화물)2021-02-18

    2 trial sites

  • Bioequivalence파마파록세틴씨알정25밀리그램(파록세틴염산염수화물)2021-01-27

    2 trial sites

  • Phase 1KP2012020-09-29

    2 trial sites

  • Bioequivalence올자펙스정10밀리그램(올란자핀)2020-05-26

    2 trial sites

  • Bioequivalence라베프린정20밀리그램(라베프라졸나트륨)2020-02-24

    2 trial sites

  • Bioequivalence파마파록세틴씨알정25밀리그램(파록세틴염산염수화물)2020-01-03

    2 trial sites

  • Bioequivalence파마파록세틴씨알정25밀리그램(파록세틴염산염수화물)2020-01-03

    2 trial sites

  • Bioequivalence아라빌정10밀리그램2019-11-06

    2 trial sites

  • Phase 2STH-KPO17012019-08-01

    3 trial sites

  • Bioequivalence리가린캡슐150mg(프레가발린)2018-12-27

    2 trial sites

  • Bioequivalence파마설트랄린염산염정50mg2018-10-08

    2 trial sites

  • Bioequivalence파마라사길린정(라사길린메실산염)2018-10-05

    2 trial sites

  • Bioequivalence프레토정(클로피도그렐황산염)2017-11-13

    2 trial sites

  • Bioequivalence바스티아정 23 밀리그램2017-08-16

    2 trial sites

  • Bioequivalence로피니롤서방정2mg(가칭)2017-03-09

    2 trial sites

  • Bioequivalence파마페노피브레이트콜린캡슐(가칭)(페노피브레이트콜린)2016-12-16

    2 trial sites

  • Bioequivalence파마블로난세린정8밀리그램(가칭)2016-10-05

    2 trial sites

  • Bioequivalence프레토정(클로피도그렐황산염)2015-12-03

    2 trial sites

  • Bioequivalence파마날트렉손정50mg(가칭)2015-10-23

    2 trial sites

  • Bioequivalence콜리티린정400밀리그램2015-06-04

    2 trial sites

  • Bioequivalence사로프람정20mg2015-04-28

    2 trial sites

  • Bioequivalence바스티아오디정10밀리그램2015-04-21

    2 trial sites

  • Bioequivalence쿠에티아핀푸마르산염2014-01-27

    2 trial sites

  • Bioequivalence파마주석산졸피뎀정2013-12-20
  • Bioequivalence파마리팍시민정(리팍시민)2013-05-21

    2 trial sites

  • Bioequivalence알빅스정(염산메만틴)2013-01-04
  • Bioequivalence파마필로카르핀정(필로카르핀염산염)2012-12-31

    2 trial sites

R&D and key agreements

Source: DART corporate disclosure

대구 첨복단지 신약연구센터 · 운영 중(2018년 7월 개소) · Plans specialized research in biologics, DDS-based improved new drugs, and contrast agents, plus national R&D projects

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 27 more patents

AI reads

MAA server logs · IP-verified
38
Times AI engines pulled KOREA PHARMA Co., Ltd.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

38
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

6
live 0
Last 7 days
31
live 0
Last 30 days
38
live 0
All time
  • OpenAIOAI-SearchBot32
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2
  • MicrosoftBingbot1
  • GoogleGoogleOther1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 8, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for KOREA PHARMA Co., Ltd. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · products. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition